Description: ImageDescription: Image

Description: image

 

Description: image

Description: image




Two examples of quality outcomes through implementation of URA Rx signature programs:

Example 1:

Oral Cancer Therapy

The Need

Patients on oral chemotherapy were experiencing problems with adherence. The side effects caused patients to stop taking their medication. The patients did not restart medication until their next scheduled office visit resulting in suboptimal dosing.

A system was needed to promote increased adherence and decrease dose interruptions!

Our Solution

URA Rx designed a structured outbound nurse interventions program for this product. The program provided patients with counseling and support before side effects emerged! URA Rx nurse support then continued through ongoing treatment cycles. Patients were also encouraged to work with their healthcare provider to manage side effects as needed. The program also included educational support and adverse event reporting. HIPAA-compliant data was available to the brand team on an ongoing basis.

Our Results

Patients completed therapeutic cycles increased 136% and grade 3/4 side effects decreased by 40% as documented in ONS Abstract #2728, published in the Oncology Nursing Forums, May 2008.

Description: Cycles Completed

 


Example 2:

IV Chemotherapy

The Need

Patients on an IV chemotherapy were increasingly non-adherence through an extended course of therapy. Side effeects caused patients to stop their medication. Mental and physical experience of side effects continued at home. Missed cycles results in sub-optimal dosing. A system was needed to provide ongoing patient support between clinic visits to promote increased adherence and decrease dose delays.

Our Solution

URA Rx designed an intensive nurse intervention program with both outbound and inbound components. The program provided patients with counseling and support pre- and post-infusion.

Our interventions:

  • Facilitated patient management of side effects

  • Encouraged adherence to physicians instructions

  • Underscored the need for uninterrupted therapy to achieve optimal results

This program also included continuous educational support and adverse event reporting. HIPAA-compliant data was available to the brand team on an ongoing basis.

Our Results

Data was collected on a total of 617 patients enrolled in the URA Rx patient support program. The average number of cycles completed by patients enrolled in the URA Rx progrm was nearly twice the number in the control group: 3.8 cycles versus 2 cycles in the control group. Completed therapeutic cycles increased 90%.

Description: chart 2 


Contact us

Description: image

 

Description: image